- Home
- GLPI vs MRNA Comparison
GLPI vs MRNA Comparison
Compare GLPI & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPI
- MRNA
- Stock Information
- Founded
- GLPI 2013
- MRNA 2010
- Country
- GLPI United States
- MRNA United States
- Employees
- GLPI N/A
- MRNA N/A
- Industry
- GLPI Real Estate Investment Trusts
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GLPI Real Estate
- MRNA Health Care
- Exchange
- GLPI Nasdaq
- MRNA Nasdaq
- Market Cap
- GLPI 13.1B
- MRNA 11.1B
- IPO Year
- GLPI N/A
- MRNA 2018
- Fundamental
- Price
- GLPI $48.00
- MRNA $33.30
- Analyst Decision
- GLPI Buy
- MRNA Hold
- Analyst Count
- GLPI 17
- MRNA 19
- Target Price
- GLPI $53.62
- MRNA $48.13
- AVG Volume (30 Days)
- GLPI 1.4M
- MRNA 9.9M
- Earning Date
- GLPI 07-24-2025
- MRNA 07-31-2025
- Dividend Yield
- GLPI 6.36%
- MRNA N/A
- EPS Growth
- GLPI 4.14
- MRNA N/A
- EPS
- GLPI 2.83
- MRNA N/A
- Revenue
- GLPI $1,550,817,000.00
- MRNA $3,177,000,000.00
- Revenue This Year
- GLPI $5.97
- MRNA N/A
- Revenue Next Year
- GLPI $3.08
- MRNA $9.70
- P/E Ratio
- GLPI $16.91
- MRNA N/A
- Revenue Growth
- GLPI 6.14
- MRNA N/A
- 52 Week Low
- GLPI $44.48
- MRNA $23.15
- 52 Week High
- GLPI $52.60
- MRNA $129.39
- Technical
- Relative Strength Index (RSI)
- GLPI 56.15
- MRNA 70.05
- Support Level
- GLPI $47.17
- MRNA $29.72
- Resistance Level
- GLPI $48.57
- MRNA $34.39
- Average True Range (ATR)
- GLPI 0.76
- MRNA 1.48
- MACD
- GLPI 0.12
- MRNA 0.68
- Stochastic Oscillator
- GLPI 72.79
- MRNA 88.62
About GLPI Gaming and Leisure Properties Inc.
Gaming and Leisure Properties Inc, or GLP, is a real estate investment property trust whose primary business consists of acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. The GLPI's portfolio consisted of interests in sixty one gaming and related facilities, the real property associated with thirty four gaming and related facilities operated by PENN, the real property associated with six gaming and related facilities operated by Caesars Entertainment Corporation.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.